- Home
- TNGX vs SR Comparison
TNGX vs SR Comparison
Compare TNGX & SR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | SR |
|---|---|---|
| Founded | 2014 | 1857 |
| Country | United States | United States |
| Employees | N/A | 3497 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TNGX | SR |
|---|---|---|
| Price | $29.96 | $78.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $21.78 | ★ $91.33 |
| AVG Volume (30 Days) | ★ 6.8M | 730.9K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.68% |
| EPS Growth | ★ 26.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,384,000.00 | N/A |
| Revenue This Year | N/A | $6.81 |
| Revenue Next Year | N/A | $2.31 |
| P/E Ratio | ★ N/A | $19.47 |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $5.48 | $71.24 |
| 52 Week High | $34.39 | $95.31 |
Technical Indicators
Market Signals| Indicator | TNGX | SR |
|---|---|---|
| Relative Strength Index (RSI) | 55.19 | 42.92 |
| Support Level | $27.65 | $75.85 |
| Resistance Level | $34.39 | $80.95 |
| Average True Range (ATR) | 1.99 | 1.70 |
| MACD | -0.28 | 0.36 |
| Stochastic Oscillator | 34.79 | 51.08 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About SR Spire Inc.
Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.